<p>After tumor induction with LMeC melanoma cells (5×10<sup>6</sup> cells), mice were randomly divided into five groups. The control group was treated with a circumtumoral injection of phosphate-buffered saline (PBS) (n = 4). The cisplatin and combination group were treated with intraperitoneal injection of low-dose cisplatin (2 mg/kg) (n = 4). The cAT-MSC-Mock, cAT-MSC-IFN-<i>β</i> and combination group were treated with a circumtumoral injection of each cAT-MSCs (5×10<sup>5</sup>) in PBS 3 times at 3 days interval. The size of each mass was measured every 3 days. Three days after the last injection, mice were sacrificed and tumor tissue was harvested for fluorescence microscopy analysis.</p
Abstract Background Primary cytoreductive surgery fol...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...
<p>(<b>A</b>) B16-OVA or (<b>B</b>) B16-F10 tumor-bearing mice were treated with PTT then rechalleng...
<p>After 11 days of tumor inoculation, tumors were touchable. Then mice were randomly regrouped (n =...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...
<p>(A) Tumors growth was measured from day 20–32 (post-cell injection) and treated every other day *...
<p>BALB/cJ mice implanted with 7,500 4T1-Luc2GFP cells were treated with the maximal tolerated dose ...
<p>(A) Treatment of Krebs-2 and LLC tumors. Scheme 1 (prophylactic): Mice were injected with DC vacc...
<p><b>A</b>) NSG mice were subcutaneously injected in the right flank with 2x10<sup>7</sup> MCV-posi...
<p><b>(A)</b> Time schedule outlining the different treatments used. BALB/c mice (10–12 mice/group) ...
<p>C57BL/6 mice were injected s.c. in one flank with 640,000 wild type Panc02 cells. At 11, 18, and ...
<p>C57BL/6 mice (5 mice/group) were challenged sequentially with TC-1 tumor cells on day 0 (right fl...
Abstract Background Primary cytoreductive surgery followed by adjuvant chemotherapy is the standard ...
<p><b>A</b>. DU145 or PC3 cells were inoculated subcutaneously into nude mice. Twelve days later, th...
<p>A) shCD5EμTg mice (n = 16) and non-transgenic littermates (n = 15) were injected s.c. with 5×10<s...
Abstract Background Primary cytoreductive surgery fol...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...
<p>(<b>A</b>) B16-OVA or (<b>B</b>) B16-F10 tumor-bearing mice were treated with PTT then rechalleng...
<p>After 11 days of tumor inoculation, tumors were touchable. Then mice were randomly regrouped (n =...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...
<p>(A) Tumors growth was measured from day 20–32 (post-cell injection) and treated every other day *...
<p>BALB/cJ mice implanted with 7,500 4T1-Luc2GFP cells were treated with the maximal tolerated dose ...
<p>(A) Treatment of Krebs-2 and LLC tumors. Scheme 1 (prophylactic): Mice were injected with DC vacc...
<p><b>A</b>) NSG mice were subcutaneously injected in the right flank with 2x10<sup>7</sup> MCV-posi...
<p><b>(A)</b> Time schedule outlining the different treatments used. BALB/c mice (10–12 mice/group) ...
<p>C57BL/6 mice were injected s.c. in one flank with 640,000 wild type Panc02 cells. At 11, 18, and ...
<p>C57BL/6 mice (5 mice/group) were challenged sequentially with TC-1 tumor cells on day 0 (right fl...
Abstract Background Primary cytoreductive surgery followed by adjuvant chemotherapy is the standard ...
<p><b>A</b>. DU145 or PC3 cells were inoculated subcutaneously into nude mice. Twelve days later, th...
<p>A) shCD5EμTg mice (n = 16) and non-transgenic littermates (n = 15) were injected s.c. with 5×10<s...
Abstract Background Primary cytoreductive surgery fol...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...
<p>(<b>A</b>) B16-OVA or (<b>B</b>) B16-F10 tumor-bearing mice were treated with PTT then rechalleng...